Clinical Trials Directory

Trials / Unknown

UnknownNCT05059015

Human Papilloma Virus (HPV) Self-collection and Women Adherence

Effect of HPV Self-collection in Adherence to Cervical Cancer Screening Algorithms

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Instituto Nacional de Cancerologia, Columbia · Other Government
Sex
Female
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Despite declining mortality in high-income countries, cervical cancer continues to be a public health problem in low and middle -income countries. HPV tests have shown a better sensibility and a higher capacity of reducing mortality than cytology based-screening. Greater participation has been demonstrated with the use of HPV self-testing when it is offered to women with a poor screening history; however, it is not clear whether getting tested necessarily translates into a greater adherence to the entire clinical protocol, including diagnosis and treatment of precancerous lesions. The aim of this study is to evaluate the effect of the self-testing techniques on the participation and adherence of women to cervical cancer screening.

Detailed description

The investigators will perform a randomized clinical trial with three arms including: regular HPV with cytology triage, colpo/biopsy, and treatment if indicated; HPV self-collection without cytology triage but with colpo/biopsy and treatment if indicated, HPV self-collection with immediate treatment for women with positive test results. This study will be carried out in two different settings with differential access to diagnosis and treatment. Two methods will be used for inviting women and collecting samples: mail and door-to-door. Participation (screening uptake) and adherence to the clinical protocol (compliance with diagnosis and treatment) will be evaluated.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCERVICAL HPVA screening test with an HPV test is performed by a health professional plus cytology taking, if it reports positive, colposcopy and biopsy are taken, those with a CIN2 + report are directed to receive treatment.
DIAGNOSTIC_TESTSELF SAMPLING HPVA screening test is performed with an HPV test by self-testing, if it reports positive, women will receive ablative treatment according to eligibility criteria. If they do not meet the criteria for ablation, they will be referred for excisional treatment.

Timeline

Start date
2019-05-01
Primary completion
2020-09-24
Completion
2022-12-03
First posted
2021-09-28
Last updated
2021-12-10

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT05059015. Inclusion in this directory is not an endorsement.